arrow
Back
M

Marie‐Kristin Tilch

Johannes Gutenberg University of Mainz

4H-index
13Paper Count
31Citation Count
Published Papers 2
Publication Date
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment
err2025-08-29
err0
errOAAI
errStephanie Herold; Christian Schmidt; Carlo Visco; Marie-Kristin Tilch; Anke Ohler; Michael Unterhalt; Eva Hoster; Elisabeth Hoenig; Susanne Singer; Alessandra Tucci; Christiane Pott; Marco Ladetto; Georg Hess; Martin Dreyling
errShare
errSave
Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry
err2022-05-01
err10
errOAAI
errTilch, Marie-Kristin; Visco, Carlo; Kinda, Sandra; Hermine, Olivier; Kohn, Milena; Besson, Caroline; Lamure, Sylvain; Dulery, Remy; Ragaini, Simone; Eyre, Toby A.; Van Meerten, Tom; Ohler, Anke; Eckerle, Steffen; Dreyling, Martin; Hess, Georg; Gine, Eva; da Silva, Maria Gomes
errShare
errSave